Pediatric buprenorphine IV

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

1 post / 0 new
Elizabeth Rogers
Elizabeth Rogers's picture
Offline
Last seen: 1 year 1 month ago
Joined: 12/11/2019 - 16:22
Pediatric buprenorphine IV

We are looking for recommendations or best practices for use of buprenorphine IV in pediatric patients. This medication has recently been added to our formulary - we are a free standing pediatric hospital.

- buprenorphine is supplied as 0.3mg/mL
- pediatric dosing is 2 to 6mcg/kg/dose every 4 to 6 hours IV undiluted

We are looking to implement risk reduction strategies throughout the medication use process, including CPOE build, that will prevent potential error with this medication.

Do you use this medication in pediatric patients? If so, what strategies have you implemented to ensure safe use?

Thank you
Elizabeth